Afya (NASDAQ:AFYA – Get Free Report)‘s stock had its “sell” rating reissued by investment analysts at Citigroup in a research note issued to investors on Friday,Benzinga reports. They presently have a $15.00 price objective on the stock, down from their prior price objective of $18.00. Citigroup’s price target indicates a potential downside of 10.93% from the company’s current price.
A number of other equities analysts have also weighed in on the stock. The Goldman Sachs Group began coverage on shares of Afya in a research report on Tuesday, December 3rd. They issued a “sell” rating and a $16.00 price objective for the company. JPMorgan Chase & Co. cut their price target on Afya from $25.00 to $20.50 and set a “neutral” rating for the company in a report on Friday, January 17th. Two investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $18.00.
View Our Latest Stock Analysis on AFYA
Afya Trading Up 2.8 %
Hedge Funds Weigh In On Afya
Several institutional investors and hedge funds have recently bought and sold shares of AFYA. Point72 Asset Management L.P. purchased a new stake in shares of Afya during the 3rd quarter valued at $842,000. State Street Corp grew its position in Afya by 118.2% during the third quarter. State Street Corp now owns 73,098 shares of the company’s stock valued at $1,248,000 after acquiring an additional 39,592 shares during the period. Erste Asset Management GmbH purchased a new stake in Afya during the third quarter valued at about $822,000. Millennium Management LLC increased its stake in Afya by 45.0% during the second quarter. Millennium Management LLC now owns 291,164 shares of the company’s stock worth $5,139,000 after acquiring an additional 90,383 shares during the last quarter. Finally, Cubist Systematic Strategies LLC raised its holdings in shares of Afya by 136.9% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 35,254 shares of the company’s stock worth $622,000 after purchasing an additional 20,370 shares during the period. Institutional investors and hedge funds own 88.02% of the company’s stock.
About Afya
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Featured Articles
- Five stocks we like better than Afya
- What is the FTSE 100 index?
- Commvault Systems: Share Price Primed to Vault Higher in 2025
- Options Trading – Understanding Strike Price
- 3 Unsung Beneficiaries of the Stargate Project
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Starbucks’ CEO-Led Turnaround Gains Traction: New Highs Likely
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.